Correlation Between Elevation Oncology and Amylyx Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Elevation Oncology and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Elevation Oncology and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Amylyx Pharmaceuticals.

Diversification Opportunities for Elevation Oncology and Amylyx Pharmaceuticals

0.31

Correlation Coefficient

Elevation Oncology  Amylyx Pharmaceuticals

Weak diversification

The 3 months correlation between Elevation and Amylyx is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Amylyx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Elevation Oncology and Amylyx Pharmaceuticals

Given the investment horizon of 90 days Elevation Oncology is expected to generate 1.32 times more return on investment than Amylyx Pharmaceuticals. However, Elevation Oncology is 1.32 times more volatile than Amylyx Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Amylyx Pharmaceuticals is currently generating about -0.26 per unit of risk. If you would invest  61.00  in Elevation Oncology on September 22, 2024 and sell it today you would lose (3.00) from holding Elevation Oncology or give up 4.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Elevation Oncology  vs.  Amylyx Pharmaceuticals

Elevation Oncology

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Elevation Oncology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Elevation Oncology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Amylyx Pharmaceuticals

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Elevation Oncology and Amylyx Pharmaceuticals

The main advantage of trading using opposite Elevation Oncology and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.

The idea behind Elevation Oncology and Amylyx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.